IPO

News

BioNTech and Vir prepare mega-IPOs after flurry of launches

Two of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, after a flurry of smaller stock market launches last week.

News

Denmark's Genmab prepares for $500m US IPO

Antibody-based drugs firm Genmab, noted for developing the blood cancer drug Darzalex with Johnson & Johnson’s Janssen unit, is preparing for a $500 million US IPO.

News

Digital health firms prepare for multi-billion dollar IPOs

A gang of digital health start-ups worth a combined $7.6 billion are preparing for IPOs after three years of inactivity, according to a press report.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Alector kicks off biotech IPOs after US government shutdown

The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a knock-on effect on the stock market because of cutbacks at the Securities and Exchange

News

Moderna shares slide after record $604m US listing

RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut.

News